25亿美元!礼来拟收购Scorpion,获得一款变构PI3Kα抑制剂

Medaverse
11 Jan

据英国《金融时报》报道,全球市值最大的制药商礼来(Eli Lilly)正在就以高达25亿美元的价格收购美国癌症生物技术公司Scorpion Therapeutics进行深入谈判。拟议的交易包括10亿美元的预付款,以及总额高达15亿美元的潜在里程碑付款。Scorpion Therapeutics以其针对与乳腺癌、妇科癌和头颈癌相关的特定突变的先导药物而闻名,该药物目前正在进行2期临床试验。此次收购...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10